Word on the street is that marijuana in the US might soon be classified as not as threatening as LSD…
A healthcare policy change passed in France is likely to see the country quickly targeted by medicinal cannabis companies with…
Over the years, the Australian cannabis market has consistently posted revenue growth and is expected to be valued at $1.1…
The company at the forefront of the cannabis sector has also ventured into the psychedelic therapy treatment industry, demonstrating a…
Although it doesn’t apply to me, many of you may remember the early mornings during adolescence when you were throwing…
Little Green Pharma (ASX: LGP) has been on a roll this quarter. Increasing cash receipts by 35% from $4.4 million…